V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

AtriCure Executive Compensation (FY25)

ATRC · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 19, 2026
243 figures on this page: 232 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
Michael Carrel was paid $9,217,620 in total compensation as President, Chief Executive Officer and Director for fiscal 2025, and Carrel's total was 16.7% lower than the $11,070,400 reported for fiscal 2024. For fiscal 2025, the company reported a chief executive pay ratio of 64:1, against median employee compensation of $144,309. For fiscal 2025, shareholders backed the say-on-pay proposal with 95.7% of votes cast including abstentions in favor at the meeting held May 18, 2026. The disclosed peer group names Alphatec Holdings, Inc., Artivion, Inc., Axogen, Inc., Glaukos Corporation and Haemonetics Corporation, among others.
Chief executive, fiscal 2025
◇
Michael Carrel
Latest say-on-pay support
=
May 18, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Michael Carrel: $11,070,400 → $9,217,620 (16.7% lower)
Say-on-pay support: 78.7% → 95.7% (17.0 points higher)
CEO pay ratio: 83:1 → 64:1 (22.9% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is AtriCure's chief executive and what were they paid?
Michael Carrel was paid $9,217,620 in total compensation as President, Chief Executive Officer and Director for fiscal 2025. Carrel's total was 16.7% lower than the $11,070,400 reported for fiscal 2024.
What was AtriCure's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 95.7% of votes cast including abstentions in favor at the meeting held May 18, 2026.
Which companies are in AtriCure's peer group?
The disclosed peer group names Alphatec Holdings, Inc., Artivion, Inc., Axogen, Inc., Glaukos Corporation and Haemonetics Corporation, among others.
What is AtriCure's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 64:1, against median employee compensation of $144,309.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Carrel
President and Chief Executive Officer
◇—◇—◇—◇◇
Douglas Seith
Chief Operating Officer
◇—◇—◇—◇◇
Angela Wirick
Chief Financial Officer
◇—◇—◇—◇◇
Salvatore Privitera
Chief Technical Officer
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Carrel
President and Chief Executive Officer
◇—◇—◇—◇◇
Douglas Seith
Chief Operating Officer
◇—◇—◇—◇◇
Angela Wirick
Chief Financial Officer
◇—◇—◇—◇◇
Justin Noznesky
Chief Marketing and Strategy Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Carrel
President, Chief Executive Officer and Director
◇—◇—◇—◇◇
Douglas Seith
Chief Operating Officer
◇—◇—◇—◇◇
Angela Wirick
Chief Financial Officer
◇—◇—◇—◇◇
Salvatore Privitera
Chief Technical Officer
◇—◇—◇—◇◇
Justin Noznesky
Chief Marketing and Strategy Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Angela L. WirickRSU◇——◇——◇
Angela L. WirickPSU◇◇◇—◇—◇
Douglas J. SeithPSU◇◇◇—◇—◇
Douglas J. SeithRSU◇——◇——◇
Justin J. NozneskyRSU◇——◇——◇
Justin J. NozneskyPSU◇◇◇—◇—◇
Michael H. CarrelRSU◇——◇——◇
Michael H. CarrelPSU◇◇◇—◇—◇
Salvatore PriviteraRSU◇——◇——◇
Salvatore PriviteraPSU◇◇◇—◇—◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Salvatore PriviteraRSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Justin NozneskyRSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Douglas SeithPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Michael CarrelRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Angela WirickRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Robert S. White
Board chair
◇◇————◇
Regina E. Groves
◇◇————◇
Sven A. Wehrwein
◇◇————◇
Karen N. Prange
◇◇————◇
Deborah H. Telman
◇◇————◇
B. Kristine Johnson
◇◇————◇
Shlomo Nachman
◇◇————◇
Maggie Yuen
◇◇————◇
Michael H. Carrel served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee member◇
Compensation committee member◇
Nominating and governance member◇
Equity is delivered as Restricted Stock.
Stock ownership guideline: 3x annual cash retainer

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec Holdings, Inc. ATEC
  • Artivion, Inc. AORT
  • Axogen, Inc. AXGN
  • Glaukos Corporation GKOS
  • Haemonetics Corporation HAE
  • Inari Medical, Inc. NARI
  • Inspire Medical Systems, Inc. INSP
  • Insulet Corporation PODD
  • iRhythm Holdings, Inc. IRTC
  • LivaNova Plc LIVN
  • Nevro Corp NVRO
  • Penumbra, Inc. PEN
  • STAAR Surgical Company STAA
  • Tactile Systems Technology, Inc. TCMD
  • Tandem Diabetes Care, Inc. TNDM

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 18, 2026=◇◇◇
2024May 19, 2025=◇◇◇
2023May 13, 2024=◇◇◇
2022May 25, 2023=◇◇◇
2021May 25, 2022=◇◇◇
2020May 20, 2021=◇◇◇
2019May 20, 2020=◇◇◇
2018May 22, 2019=◇◇◇
2017May 22, 2018=◇◇◇
2016May 24, 2017=◇◇◇
2015May 25, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when AtriCure files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact AtriCure disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where AtriCure sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether AtriCure's disclosed peer group is defensible, who names AtriCure back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
243 figures on this page: 232 cited to the filing that reported them, 11 calculated from figures it prints.
232 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001323885-26-000025
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001323885-26-000010
    CEO Pay Ratio · Director Compensation · Director Compensation Table · Grants of Plan-Based Awards · and 2 more sections
  3. 0001323885-25-000050
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001323885-25-000037
    Summary Compensation Table
  5. 0001323885-24-000068
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001323885-24-000055
    Summary Compensation Table
  7. 0001323885-23-000053
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001323885-22-000063
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001193125-21-170877
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001323885-20-000036
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001323885-19-000022
  12. 0001323885-18-000041
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001323885-17-000044
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0001323885-16-000043
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “AtriCure executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ATRC (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about AtriCure and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers AtriCure discloses

The companies named in ATRC's own disclosed peer group.

Artivion, Inc.Axogen, Inc.Glaukos CorporationHaemonetics CorporationInspire Medical Systems, Inc.Insulet CorporationiRhythm Holdings, Inc.LivaNova PlcPenumbra, Inc.STAAR Surgical CompanyTactile Systems Technology, Inc.Tandem Diabetes Care, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy